PharmaEngine, Inc. (TPEX:4162)
Taiwan · Delayed Price · Currency is TWD 72.00
+1.60 (2.27%)
Oct 9, 2025, 1:30 PM CST
PharmaEngine Market Cap
PharmaEngine has a market cap or net worth of 10.34 billion as of October 10, 2025. Its market cap has decreased by -12.30% in one year.
Market Cap
10.34B
Enterprise Value
4.95B
Revenue
2.48B
Ranking
n/a
PE Ratio
6.36
Stock Price
72.00
Market Cap Chart
Since September 1, 2011, PharmaEngine's market cap has increased from 5.38B to 10.34B, an increase of 92.33%. That is a compound annual growth rate of 4.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2025 | 10.34B | -20.27% |
| Dec 31, 2024 | 12.97B | -14.41% |
| Dec 29, 2023 | 15.16B | -15.60% |
| Dec 30, 2022 | 17.96B | 75.96% |
| Dec 30, 2021 | 10.21B | 21.08% |
| Dec 31, 2020 | 8.43B | -15.52% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 237.31B |
| PharmaEssentia | 198.23B |
| Bora Pharmaceuticals Co., LTD. | 80.80B |
| Lotus Pharmaceutical | 72.85B |
| Lumosa Therapeutics | 45.65B |
| Oneness Biotech | 31.42B |
| Polaris Group | 28.12B |
| Center Laboratories | 25.83B |